Gave a talk at StartCon about the future of Growth. I touch on viral marketing / referral marketing, fake news and social media, and marketplaces. Finally, the slides go through future technology platforms and how things might evolve there.
The Six Highest Performing B2B Blog Post FormatsBarry Feldman
If your B2B blogging goals include earning social media shares and backlinks to boost your search rankings, this infographic lists the size best approaches.
Gave a talk at StartCon about the future of Growth. I touch on viral marketing / referral marketing, fake news and social media, and marketplaces. Finally, the slides go through future technology platforms and how things might evolve there.
The Six Highest Performing B2B Blog Post FormatsBarry Feldman
If your B2B blogging goals include earning social media shares and backlinks to boost your search rankings, this infographic lists the size best approaches.
As the impact of healthcare reform on the U.S. delivery system comes into focus, there is little doubt that it is a “game changer” for clinical engineering and biomedical equipment technology. Carol will describe and discuss the future of the CE and BMET professions under new regulations and a new payment system. She will address why medical devices will cost much more, why equipment must have longer life cycles, why CEs and BMETs will and must have more involvement in IT-related activities, how CEs’ and BMETs’ responsibilities in regulatory compliance will expand and how you can prepare for this new environment.
About Carol Davis-Smith, CCE
Career Summary
Carol Davis-Smith is a Director in Premier’s Consulting Solution Division with responsibility for the development and deployment of capital lifecycle management processes and tools to Premier staff and owners.
Education and Affiliations
Ms. Davis-Smith received a B.S. in bioengineering technology
from the University of Dayton and an M.S. in engineering from the University of Arizona. She is a certified clinical engineer and a member of the Association for the Advancement of Medical Instrumentation (AAMI). Over the past 20 years, she has presented and published papers on a variety of clinical engineering and capital contracting topics. In 2009, Ms. Davis-Smith received the AAMI Clinical Engineering Achievement Award.
The presentation describes an integrated health model for population management through the American Health Data Institute (AHDI) that has been in place for over 10 years with proven results for over 2.5 million members nationwide. The system relies on the use of sophisticated data analytics, identification of the chronically ill and those most likely to incur large claims, establishment of a regimen of care with follow up, Nurse Navigator oversight of care for the chronically ill, active management of large episodic claimants, identification of the chronically ill and triage to the most cost effective and quality medical providers, and active and effective wellness and biometric screening tools.
North Carolina Association of County Commissionersemergingissues
The cost of healthcare is weighing down household and county budgets across the state. On Friday, August 19, the Institute for Emerging Issues (IEI) moderated a session, Better Health for a Better Bottom Line, to over 40 county leaders at the North Carolina Association of County Commissioners annual conference in Concord, NC.
a part of "The Path Forward for Academic Medical Centers: Innovation", Economics and Better Health, an Economic Studies and Engelberg Center for Health Care Reform event at the Brookings Institutuion
Dr. Julie Schoenman’s presentation for the MILI Actuarial Seminar series, “A Detailed Look at US Health Care Spending,” covers recent trends in public and private spending as well as the implications of rising spending for the federal budget outlook and for consumers.
Dr. Julie Schoenman’s presentation for the MILI Actuarial Seminar series, “A Detailed Look at US Health Care Spending,” covers recent trends in public and private spending as well as the implications of rising spending for the federal budget outlook and for consumers.
The cost of healthcare is weighing down household and county budgets across the state. On Friday, August 19, the Institute for Emerging Issues (IEI) moderated a session, Better Health for a Better Bottom Line, to over 40 county leaders at the North Carolina Association of County Commissioners annual conference in Concord, NC.
Greg Poulsen, vice president of strategy for Intermountain Healthcare, gave the Salt Lake Chamber Capitol Club an inside look at the federal healthcare bill and the effect it will have on reform efforts in Utah.
David M. Schreck, MD, FACEP, FACP, FHM , Chairman, Department of Emergency Medicine at Summit Medical Group provided this presentation on health care trends as part of a community lecture series on the Berkeley Heights, NJ campus. The presentation explains the impact on patient care and how to navigate the system.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
As the impact of healthcare reform on the U.S. delivery system comes into focus, there is little doubt that it is a “game changer” for clinical engineering and biomedical equipment technology. Carol will describe and discuss the future of the CE and BMET professions under new regulations and a new payment system. She will address why medical devices will cost much more, why equipment must have longer life cycles, why CEs and BMETs will and must have more involvement in IT-related activities, how CEs’ and BMETs’ responsibilities in regulatory compliance will expand and how you can prepare for this new environment.
About Carol Davis-Smith, CCE
Career Summary
Carol Davis-Smith is a Director in Premier’s Consulting Solution Division with responsibility for the development and deployment of capital lifecycle management processes and tools to Premier staff and owners.
Education and Affiliations
Ms. Davis-Smith received a B.S. in bioengineering technology
from the University of Dayton and an M.S. in engineering from the University of Arizona. She is a certified clinical engineer and a member of the Association for the Advancement of Medical Instrumentation (AAMI). Over the past 20 years, she has presented and published papers on a variety of clinical engineering and capital contracting topics. In 2009, Ms. Davis-Smith received the AAMI Clinical Engineering Achievement Award.
The presentation describes an integrated health model for population management through the American Health Data Institute (AHDI) that has been in place for over 10 years with proven results for over 2.5 million members nationwide. The system relies on the use of sophisticated data analytics, identification of the chronically ill and those most likely to incur large claims, establishment of a regimen of care with follow up, Nurse Navigator oversight of care for the chronically ill, active management of large episodic claimants, identification of the chronically ill and triage to the most cost effective and quality medical providers, and active and effective wellness and biometric screening tools.
North Carolina Association of County Commissionersemergingissues
The cost of healthcare is weighing down household and county budgets across the state. On Friday, August 19, the Institute for Emerging Issues (IEI) moderated a session, Better Health for a Better Bottom Line, to over 40 county leaders at the North Carolina Association of County Commissioners annual conference in Concord, NC.
a part of "The Path Forward for Academic Medical Centers: Innovation", Economics and Better Health, an Economic Studies and Engelberg Center for Health Care Reform event at the Brookings Institutuion
Dr. Julie Schoenman’s presentation for the MILI Actuarial Seminar series, “A Detailed Look at US Health Care Spending,” covers recent trends in public and private spending as well as the implications of rising spending for the federal budget outlook and for consumers.
Dr. Julie Schoenman’s presentation for the MILI Actuarial Seminar series, “A Detailed Look at US Health Care Spending,” covers recent trends in public and private spending as well as the implications of rising spending for the federal budget outlook and for consumers.
The cost of healthcare is weighing down household and county budgets across the state. On Friday, August 19, the Institute for Emerging Issues (IEI) moderated a session, Better Health for a Better Bottom Line, to over 40 county leaders at the North Carolina Association of County Commissioners annual conference in Concord, NC.
Greg Poulsen, vice president of strategy for Intermountain Healthcare, gave the Salt Lake Chamber Capitol Club an inside look at the federal healthcare bill and the effect it will have on reform efforts in Utah.
David M. Schreck, MD, FACEP, FACP, FHM , Chairman, Department of Emergency Medicine at Summit Medical Group provided this presentation on health care trends as part of a community lecture series on the Berkeley Heights, NJ campus. The presentation explains the impact on patient care and how to navigate the system.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
2. Where is the Biggest Opportunity?
Let‟s use the Pareto Principle to find The Problem…
In the case of the U.S. healthcare system, approximately 80%
of all costs are from 20% of the those with chronic illnesses
Concerning the 80% chronic illness costs, what is the
main contributor to these high costs? Answer: Those who
have multiple chronic illnesses!
$13,000
$12,699
$12,000
Average Per Capita Health
$11,000
$10,000
~20% Costs
Care Spending
$9,000
$8,518
$8,000
$7,000
$6,000 $6,178
$5,000
$4,000 $4,256
~80% $3,000
$2,000 $2,241
$1,000 $850
$0
0 1 2 3 4 5+
Number of Chronic Conditions
Source: Johns Hopkins Medical Expenditure Panel Survey, 2001.
3. What are the Failure Modes to Fix?
Treatment Testing:
– Lack of studies or poor experimental design
– Comparing new drugs to the placebo
– Extrapolating data from results on animals
– Extrapolating from group to group i.e. adult data to children
Treatment Planning:
– One-at-a-time approach
– Weak patient involvement
– Doctor bias or improper framing
Treatment Measures:
– Fragmented provider delivery
– Delayed monitoring of status
– Subjective measures
Smart Treatment Planning Addresses These Common Problems!
4. Solution Overview
Natural Remedies? International Remedies?
Over the Counter?
Prescription Drugs? Diet & Nutrients?
• Target: persons with (multiple) chronic illnesses
• Improve wellness through structured treatment planning
• Through an advanced method of testing and documenting
over many weeks, or a Smart Test Plan
Solution: Optimal Treatment = Lower Costs = Best Quality of Life
5. A Case Study
Customer: 45 year old male named “Frank”
Chronic Conditions: Two
Specifics: Parkinson‟s (rigidity and bradykinesia or slowness of
movement) & Sleep Apnea: (very low oxygen levels due to snoring)
Problem: “Very tired” at his day job
Problem Duration: 1 Year
No. of Rx: 1 2 4 5 STOP!
Frank complains he Frank complains he Frank continues to
cannot sleep Dr. C is tired at work be tired during the
Sleep Study day
Prescribes Dr. A
Dr. A Confirms Dr. B
CPAP Prescribes
Prescribes Apnea Prescribes
Provolonia
Trazodone Mirapex &
Amantadine
6. A Test Plan is Developed
• Frank works with his doctor(s) to see if there are other treatments:
he chose to test a Mandibular Advancement Brace.
• After discussion, Frank‟s doctor prescribes a new medicine to
control the Parkinson‟s – Selegiline
• Taking into consideration his overall situation, a combined Smart
Test Plan was developed:
Selegiline
Mandibular 5MG Tab Amantadine Parkinsons
Cpap Advancement (AM, AM & 100MG Cap, No. of finger Tiredness Stiffness
Week 10psi Brace Noon) (AM, Noon, PM) taps/60sec Rating (1-10) Rating (1-10)
1 0 1 5 100
2 1 0 5 100
3 0 1 5 300
4 1 0 Doctors here) 5
(Checkpoint with 300
5 0 1 10 100
6 1 0 10 100
7 0 1 10 300
8 1 0 10 300
Key: 1 = Use, 0 = Do Not Use
8. •Practices will be held on Tuesday and Thursdays at Bayside (same field) 5:30 to 7:00
Case Study Conclusion
• On the last week of documenting, the Treatment Planner
shows Frank his report
• The best regiment is suggested to be:
1. Use the Brace, and
2. Use Selegine at level 10, and
3. Use Amantatine at level 300
Optimal [ ]:Cpap [ ]:MDAB Selegili Amantadi
D High 1.0 1.0 10.0 300.0
Cur
0.94183 Low
[0.0]
0.0
[1.0]
0.0
[10.0]
5.0
[300.0]
100.0 <= Optimum Levels in RED
Composite
Desirability
0.94183
No. of F
Maximum Effect of change as you
y = 122.750
d = 1.0000 move from High to Low
Tirednes
Maximum
y = 9.8750
d = 0.98611
Stiffnes
Maximum
y = 8.6250
d = 0.84722
Now Frank feels great and takes fewer treatments!
9. How is this Technology Better?
30% of
Older
Adults
Value
Gap
Frank’s
Case
New
Process
Source: www.itl.nist.gov/div898/handbook/pri/section3/pri3.htm
10. A Case Study with Software
Customer: 18 year old female named “McKayla”
Chronic Conditions: One
Specifics: Acne
Problem: “OMG so totally annoying”
Problem Duration: Years
McKayla chooses
the treatments to
use in her Test
Plan.
13. Software Session – Review
1. The conventional number
of combinations to try
would normally be 8 (or
3
2 ). We require only a
fraction (½ or ¼) of this
time. This saves weeks or
months of time!
2. Sometimes, the
recommended combination
was not included in the
original test plan. There is
no need to test every
combination!
3. The recommended
combination rating is
better than those tried in
all the plan steps. This
leads to optimum
comfort.
14. Software Session - Safety
Drugs include
only
those that have
been already
Safety checks for dual
approved by the
therapy
FDA
Safety checks for
adverse reactions
on-line!
15. Solution System Process
Current Traditional Process:
Chronic Choose a Use OK Y Done
Condition Treatment Treatment ?
N
Multiple “go backs“ cause a waste of This may not be
time and additional pain the best treatment
New Smart Treatment Process:
Get the
Choose a Use
Chronic Log Best
Condition Treatment Test Results Med
Done
Test Plan Plan Mix
16. This Tool is Not…
• Meant to replace advice from your Doctor
• Meant to replace instructions from your Pharmacist
• To be a sole source of information to which decisions
or diagnoses are made
• Always accurate – it is as good as your data--and just
like the X-ray for example, the results must be read
and verified
• A tool where you can copy the results and use on
another person
• An „expert‟ system to cure all
• A rationing system
Smart Plan + Medical Knowledge = Optimal Comfort
17. Why Optimization?
Traditional approaches On-target Smart
Developing the
miss the mark, often Treatment Planning
Smart Test Plan
resulting in: will result in:
is finding where
• Pain • Comfort
your target is,
• Increased clinic visits • Reduced clinic visits
and taking aim • Poor quality of life • Quality of life
• Loss of work • High functioning
• Lower Costs!
18. Market Opportunity - Size
• Target customers are the chronically diagnosed who are starting or
altering their treatment regiment. They need to know…
o what treatment options are effective (Screening)?
o If there are treatment levels with better efficacy?
o If there is effective natural alternatives?
o if there are options which are just as effective but at a lower cost?
• Sample Target Community and Market Size:
Condition Prevalence in U.S. Customers Risk Factor Unbiased Measure (5=Best)
Canker Sore 10,000,000 10,000 1 5
Migraine Headache 23,000,000 23,000 1 2
Prostate Enlargement 15,000,000 15,000 1 3
Acne Rosacea 13,000,000 13,000 1 3
Osteoarthritis 16,000,000 16,000 1 2
Sleep Apnea 16,000,000 16,000 1 2
Acne Vulgaris 4,600,000 4,600 1 5
Peptic Ulcer 20,000,000 20,000 1 1
Psoriasis 4,000,000 4,000 1 5
Epilepsy 2,500,000 2,500 1 4
Parkinson's Disease 1,500,000 1,500 1 5
Glaucoma 3,500,000 3,500 1 2
Gout 2,300,000 2,300 1 3
Source of Quantity: "The Essential Guide to Chronic Illness" by J.W. Long M.D.
19. Market Opportunity - Trends
• According to a survey by the AMA:
– 68% of older adults who regularly take at least one prescription drug also use
over-the-counter medication, dietary supplements, or both
– 30% of older adults use at least 5 prescription drugs
– One in 25, or 2.2 million older adults, are taking drug combinations that place
them at some level of safety risk.
• People want to know more information about their treatments:
– 25% of U.S adults who are internet users “often” look for information online
about health topics (Harris Interactive‟s Healthcare News, Volume 8, Issue 8,
August 2008)
• Smart Planning – Solution to an Information Problem
– A solution for the active and involved patient
– Efficient planning, data driven and unbiased
– Personal Report leads to comfort
20. Market Opportunity - Segmentation
TARGET SEGMENT 1 TARGET SEGMENT 2
Who Are They: Empowered patients with a Wellness providers' who seek
chronic illnesses care for their client
Descriptive Traits: •Mid to high income •M.D. in a clinic
•Internet user •Wellness nurse providing
personal case management
Behavior Base: •Persistent – wants the best •Open mind to new tool or
treatment approach
•Tolerant of collecting and
recording data
Customer Analysis: •Dissatisfied with circumstances •Clinic Management
or quality •Insurer Management
Competitor Analysis: •Information sites (WebMD) •Provider apathy
Environmental •Strong disclaimer •Controls & safety checks
Analysis: •Controls & safety checks
This Tool is the Key to a Successful Disease Management Program!
21. Potential Sales Model
• Distribution Channels
o Individual consumer market – users of internet, active patients
seeking better comfort
o Physicians, Nurse advocates, and other health care providers
interested in getting health care information on their patient and
possibly decreasing costs
• Sales cycle
o The customers will come directly to the website, register, pay
online, and use the service for a year
o The „subscription fee‟ approach allows for longer steps and better
quality results
o Returning users will include clients with any changes to their
conditions or treatments
22. Competition Vs. Smart Planning
• Competition or Risks:
o The current process: visits to physicians offices where one-at-a-time
method is de facto
o Customer Focus: Smart Test Plans, especially a plan with natural remedies,
may take months, requiring data record keeping and recording
o Health Information web sites offer symptom checkers:
•WebMD.com
•Medicinenet.com
o Future personalized treatment planning analysis based on individual DNA
• Smart Planning:
o A personal report on the effects of treatments
o Non-biased aggregator of information, include Rx and natural options side-
by-side
o Only health information site which provides effect of a treatment on an
individual
o Optimal med mix is found – faster!
23. A Competitor Compared
Web Portal Smart Treatment
Area
i.e. WebMD® Planning
General –Assumes Individual – Provides
Information everybody responds specific information unique
the same to a drug to you
Decision Tree. Mathematical optimization.
Engine Based on general Based on your individual
static content data effects
Treatment Includes herbal and
Biased to Western Rx
Options alternative
Minimal effort in
Process Effort involved in logging
information gathering,
data means greater effort,
& Results but results are
but results are actionable.
generalized
24. Summary
• Of all the areas to make an impact, chronic illnesses have
the highest overall opportunity
• There are currently many different failure modes in the
treatment of chronic illnesses – which we fix!
• Use of patented software for health treatment planning has
a clear technology advantage over the often used one-at-a-
time method
• The case studies and software prototype indicate that a
Smart Treatment Plan App is feasible to develop
• Market size and health trends support the idea that this
project will see success entering the marketplace
• The optimal treatment mix found as the result of a Test
Plan, will lower healthcare costs to an individual, and
therefore to society as a whole
26. Back-up Reference
• Average per capita spending on
people with one or more chronic
conditions is more than five
times greater than spending on
$12,699 people without any chronic
$13,000
$12,000 conditions. ($850 for people with
Average Per Capita Health
$11,000 no conditions compared to
$10,000 $4,398 for people with one or
Care Spending
$9,000 more conditions.)
$8,518
$8,000 • Compared to individuals with
$7,000 no chronic conditions:
$6,000 $6,178 • Spending is over two and
$5,000 a half times greater for
$4,000 $4,256 someone with one chronic
$3,000
condition.
$2,241 • Spending is over seven
$2,000
times greater for someone
$1,000 $850 with three chronic
$0
0 1 2 3 4 5+
conditions.
• Spending is almost 15
Number of Chronic Conditions
times greater for someone
with five or more chronic
Johns Hopkins University, Partnership for Solutions
conditions.
Source: Medical Expenditure Panel Survey, 2001.